iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares BLISSGVS BLISS GVS PHARMA LIMITED INE416D01022 Board Meeting New 2026-02-10 Yes 2026-01-01 2026-02-12 Dividend Financial results Unaudited Standalone And Consolidated Quarterly December 2025 Interim We wish to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, February 10, 2026, at the registered office of the Company, inter alia, to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2025 and Interim Dividend, if any, for the financial year 2025-2026.